Clinical Trial Update: Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of an HPV-specific immunotherapy in participants with HPV-associated head and neck squamous cell carcinoma completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• HPV-specific immunotherapy (Inovio Pharmaceuticals investigational therapy)

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Head and Neck Squamous Cell Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-23